Hypermarcas Cash on Hand 2012-2025 | HYPMY

Hypermarcas cash on hand from 2012 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Hypermarcas Annual Cash on Hand
(Millions of US $)
2024 $346
2023 $517
2022 $556
2021 $429
2020 $937
2019 $570
2018 $453
2017 $489
2016 $489
2015 $894
2014 $819
2013 $540
2012 $894
2011 $1,560
Hypermarcas Quarterly Cash on Hand
(Millions of US $)
2025-09-30 $347
2025-06-30 $221
2025-03-31 $304
2024-12-31 $346
2024-09-30 $592
2024-06-30 $560
2024-03-31 $645
2023-12-31 $517
2023-09-30 $455
2023-06-30 $433
2023-03-31 $210
2022-12-31 $556
2022-09-30 $428
2022-06-30 $310
2022-03-31 $309
2021-12-31 $429
2021-09-30 $619
2021-06-30 $391
2021-03-31 $326
2020-12-31 $937
2020-09-30 $969
2020-06-30 $999
2020-03-31 $527
2019-12-31 $570
2019-09-30 $353
2019-06-30 $314
2019-03-31 $317
2018-12-31 $453
2018-09-30 $393
2018-06-30 $335
2018-03-31 $300
2017-12-31 $489
2017-09-30 $443
2017-06-30 $662
2017-03-31 $691
2016-12-31 $489
2016-09-30 $466
2016-06-30 $624
2016-03-31 $634
2015-12-31 $894
2015-09-30 $532
2015-06-30 $597
2015-03-31 $618
2014-12-31 $819
2014-09-30 $806
2014-06-30 $773
2014-03-31 $621
2013-12-31 $540
2013-09-30 $951
2013-06-30 $843
2013-03-31 $916
2012-12-31 $894
2012-09-30 $1,069
2012-06-30 $1,179
2012-03-31 $1,290
2011-12-31 $1,560
2011-09-30 $1,559
2011-06-30 $1,728
2011-03-31 $1,109
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.882B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.220B 33.89
Zoetis (ZTS) United States $55.228B 19.77
Takeda Pharmaceutical (TAK) Japan $51.739B 10.56
Daiichi Sankyo, - (DSNKY) Japan $43.684B 21.75
BeOne Medicines - (ONC) Switzerland $36.626B 194.18
Sandoz Group AG (SDZNY) Switzerland $33.097B 0.00
United Therapeutics (UTHR) United States $20.770B 18.28
Merck (MKKGY) Germany $19.845B 12.23
Shionogi (SGIOY) Japan $15.823B 14.53
Neurocrine Biosciences (NBIX) United States $13.227B 31.74
Ionis Pharmaceuticals (IONS) United States $13.227B 0.00
Summit Therapeutics (SMMT) United States $13.140B 0.00
IPSEN (IPSEY) France $12.596B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.595B 0.00
Orion OYJ (ORINY) Finland $11.045B 31.56
Eisai (ESAIY) $8.889B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.576B 20.00
Grifols, S.A (GRFS) Spain $6.284B 0.00
Stevanato Group S.p.A (STVN) Italy $6.278B 35.14
Crinetics Pharmaceuticals (CRNX) United States $5.252B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.613B 0.00
Indivior (INDV) United States $4.321B 17.63
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.080B 19.37
Corcept Therapeutics (CORT) United States $3.930B 42.46
NewAmsterdam Pharma (NAMS) Netherlands $3.707B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.960B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.854B 9.11
Dyne Therapeutics (DYN) United States $2.494B 0.00
Ocular Therapeutix (OCUL) United States $2.277B 0.00
Soleno Therapeutics (SLNO) United States $2.231B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.100B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.015B 23.88
Guardian Pharmacy Services (GRDN) United States $1.995B 38.43
Ardelyx (ARDX) United States $1.788B 0.00
Harrow (HROW) United States $1.772B 108.73
Collegium Pharmaceutical (COLL) United States $1.522B 7.54
BioCryst Pharmaceuticals (BCRX) United States $1.494B 88.62
Oruka Therapeutics (ORKA) United States $1.486B 0.00
Enliven Therapeutics (ELVN) United States $1.485B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.361B 0.00
Relay Therapeutics (RLAY) United States $1.352B 0.00
Evotec AG (EVO) Germany $1.335B 0.00
Xeris Biopharma Holdings (XERS) United States $1.306B 0.00
Savara (SVRA) United States $1.174B 0.00
ARS Pharmaceuticals (SPRY) United States $1.125B 0.00
Cronos Group (CRON) Canada $1.025B 0.00
Xencor (XNCR) United States $1.012B 0.00
Theravance Biopharma (TBPH) United States $0.996B 41.81
Esperion Therapeutics (ESPR) United States $0.849B 0.00
KalVista Pharmaceuticals (KALV) United States $0.828B 0.00
Nektar Therapeutics (NKTR) United States $0.789B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.727B 17.19
Rigel Pharmaceuticals (RIGL) United States $0.725B 6.48
ProKidney (PROK) United States $0.701B 0.00
Bioventus (BVS) United States $0.641B 13.14
Lexeo Therapeutics (LXEO) United States $0.593B 0.00
Organogenesis (ORGO) United States $0.537B 0.00
Lyell Immunopharma (LYEL) United States $0.505B 0.00
Elite Pharmaceuticals (ELTP) United States $0.497B 0.00
Siga Technologies (SIGA) United States $0.472B 6.46
Zevra Therapeutics (ZVRA) United States $0.472B 0.00
4D Molecular Therapeutics (FDMT) United States $0.429B 0.00
Aquestive Therapeutics (AQST) United States $0.428B 0.00
Altimmune (ALT) United States $0.423B 0.00
Nature's Sunshine Products (NATR) United States $0.390B 23.25
USANA Health Sciences (USNA) United States $0.377B 10.51
Akebia Therapeutics (AKBA) United States $0.372B 0.00
Profound Medical (PROF) Canada $0.314B 0.00
Avalo Therapeutics (AVTX) United States $0.309B 0.00
Relmada Therapeutics (RLMD) United States $0.301B 0.00
Achieve Life Sciences (ACHV) Canada $0.301B 0.00
Aclaris Therapeutics (ACRS) United States $0.288B 0.00
Silence Therapeutics (SLN) United Kingdom $0.279B 0.00
OmniAb (OABI) United States $0.275B 0.00
Fractyl Health (GUTS) United States $0.274B 0.00
Heron Therapeutics (HRTX) United States $0.273B 0.00
Protara Therapeutics (TARA) United States $0.271B 0.00
Larimar Therapeutics (LRMR) United States $0.269B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Enlivex Therapeutics (ENLV) Israel $0.226B 0.00
Journey Medical (DERM) United States $0.210B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
VAXART, INC (VXRT) United States $0.192B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.192B 0.00
MediWound (MDWD) Israel $0.191B 0.00
Minerva Neurosciences (NERV) United States $0.187B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Century Therapeutics (IPSC) United States $0.178B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.161B 0.00
AleAnna (ANNA) United States $0.155B 0.00
Surrozen (SRZN) United States $0.154B 0.00
Karyopharm Therapeutics (KPTI) United States $0.150B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.140B 0.00
Prelude Therapeutics (PRLD) United States $0.138B 0.00
Context Therapeutics (CNTX) United States $0.137B 0.00
Incannex Healthcare (IXHL) Australia $0.135B 0.00
Inhibikase Therapeutics (IKT) United States $0.129B 0.00
Pyxis Oncology (PYXS) United States $0.128B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.128B 0.00
Unicycive Therapeutics (UNCY) United States $0.126B 0.00
Avita Medical (RCEL) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
Cardiol Therapeutics (CRDL) Canada $0.096B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.093B 39.53
Korro Bio (KRRO) United States $0.084B 0.00
Gain Therapeutics (GANX) United States $0.082B 0.00
PolyPid (PYPD) Israel $0.074B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.071B 59.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Plus Therapeutics (PSTV) United States $0.068B 0.00
Arch Biopartners (ACHFF) Canada $0.067B 0.00
NRx Pharmaceuticals (NRXP) United States $0.066B 0.00
Metagenomi (MGX) United States $0.066B 0.00
Rafael Holdings (RFL) United States $0.064B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Assertio Holdings (ASRT) United States $0.060B 0.00
Lite Strategy (LITS) United States $0.053B 0.00
Acrivon Therapeutics (ACRV) United States $0.051B 0.00
Nutriband (NTRB) United States $0.051B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Lipocine (LPCN) United States $0.050B 0.00
Talphera (TLPH) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Wellgistics Health (WGRX) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
FibroGen (KYNB) United States $0.037B 0.00
Jupiter Neurosciences (JUNS) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.031B 0.00
Natural Alternatives (NAII) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Klotho Neurosciences (KLTO) United States $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
Scienture Holdings (SCNX) United States $0.022B 0.00
Inotiv (NOTV) United States $0.021B 0.00
Liminatus Pharma (LIMN) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Vyome Holdings (HIND) United States $0.018B 0.00
Iterum Therapeutics (ITRM) Ireland $0.017B 0.00
China SXT Pharmaceuticals (SXTC) China $0.017B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.014B 0.00
CASI Pharmaceuticals (CASI) China $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.01
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
Ainos (AIMD) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Salarius Pharmaceuticals (DCOY) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Lyra Therapeutics (LYRA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00